Eduard Antonie van Bodegraven, Sanne Lof, Leia Jones, Béatrice Aussilhou, Gao Yong, Wei Jishu, Rosa Klotz, Dario Missael Rocha-Castellanos, Ippei Matsumato, Charles de Ponthaud, Kimitaka Tanaka, Esther Biesel, Emmanuele Kauffmann, Traian Dumitrascu, Yuichi Nagakawa, Pablo Martí-Cruchaga, Geert Roeyen, Alessandro Zerbi, Mara Goetz, Vincent de Meijer, Patrick Pessaux, Povilas Ignatavicius, Ihsan Demir, Mario Giuffrida, Bobby Tingstedt, Marco Vito Marino, Sotiris Mastoridis, Maximilian Brunner, Isabel Mora-Oliver, Cecilia Bortolato, Aisté Gulla, Thomas Apers, Hélène Hermand, Yusuke Mitsuka, Irinel Popescu, Ugo Boggi, Uwe Wittel, Satoshi Hirano, Sébastien Gaujoux, Keiko Kamei, Carlos Fernández-Del Castillo, Thilo Hackert, Jiang Kuirong, Miao Yi, Alain Sauvanet, Marc Besselink, Mohammad Abu Hilal, Safi Dokmak
OBJECTIVE: To develop a prediction model for major morbidity and endocrine dysfunction after CP which could help in tailoring the use of this procedure. SUMMARY BACKGROUND DATA: Central pancreatectomy (CP) is a parenchyma-sparing alternative to distal pancreatectomy for symptomatic benign and pre-malignant tumors in body and neck of the pancreas CP lowers the risk of new-onset diabetes and exocrine pancreatic insufficiency compared to distal pancreatectomy but it is thought to increase the risk of short-term complications including postoperative pancreatic fistula (POPF)...
December 11, 2023: Annals of Surgery